LetroHEXAL® 2,5 mg

Description

Side effects

• As a rule, adverse effects are of mild to moderate intensity and are mainly related to inhibition of oestrogen synthesis. The incidence of adverse effects is estimated as follows: incidence “very common” – >10%, “common” – >1 – <10%, “rare” – >0.1% – <1%, “rare” – >0.01 – <0.1%, “very rarely” – <0.01%, including single reports.
• Infectious and parasitic diseases: rare – urinary tract infections.
• Benign, malignant and unspecified tumours (including cysts and polyps): rarely – pain in the tumour area.
• Blood and lymphatic system disorders: uncommon – leukopenia.
• Immunological system disorders: uncommon – anaphylactic reactions.
• Metabolic and nutritional disorders: very common – hypercholesterolaemia; common – anorexia, increased appetite.
• Mental disorders: frequently – depression; rarely – anxiety (including nervousness), irritability.
• Nervous system disorders: often – headache, dizziness; rarely – somnolence, insomnia, memory impairment, sensory disturbances (including paresthesia, hypoesthesia),
  taste disturbances, episodes of cerebral circulatory disorders, carpal tunnel syndrome.
• Visual disturbances: rarely – cataracts, eye irritation, “blurred” vision.
• Cardiac disorders: rarely – palpitations*, tachycardia, ischaemic heart disease (including newly diagnosed or worsening of existing angina, angina requiring surgical intervention, myocardial infarction, myocardial ischaemia).